Ambalal Sarabhai Enterprises Ltd

Ambalal Sarabhai Enterprises Ltd

₹ 49.9 1.20%
28 May - close price
About

Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics[1]

Key Points

Business Overview:[1]
ASE is a pharmaceutical health care companies, which through its group companies, manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and abroad

  • Market Cap 383 Cr.
  • Current Price 49.9
  • High / Low 70.0 / 20.9
  • Stock P/E 67.4
  • Book Value 17.9
  • Dividend Yield 0.00 %
  • ROCE 5.85 %
  • ROE 4.24 %
  • Face Value 10.0

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 2.92% over past five years.
  • Promoter holding is low: 30.8%
  • Tax rate seems low
  • Earnings include an other income of Rs.10.4 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
48.46 42.73 56.49 43.10 54.43 43.65 46.84 35.36 44.44 36.10 40.01 43.11 54.35
56.56 35.44 46.63 37.15 53.09 42.91 46.11 33.79 41.09 40.07 39.00 40.58 49.70
Operating Profit -8.10 7.29 9.86 5.95 1.34 0.74 0.73 1.57 3.35 -3.97 1.01 2.53 4.65
OPM % -16.71% 17.06% 17.45% 13.81% 2.46% 1.70% 1.56% 4.44% 7.54% -11.00% 2.52% 5.87% 8.56%
25.31 22.60 1.99 0.65 8.54 2.69 2.38 3.06 5.71 1.37 2.85 1.63 4.79
Interest 0.54 0.59 0.34 0.33 0.45 0.43 0.45 0.56 0.99 0.95 0.92 0.99 0.90
Depreciation 0.50 0.56 0.56 0.58 0.62 0.60 0.62 0.61 0.92 1.05 1.14 1.13 0.25
Profit before tax 16.17 28.74 10.95 5.69 8.81 2.40 2.04 3.46 7.15 -4.60 1.80 2.04 8.29
Tax % 3.59% 7.45% 12.97% 38.49% 13.96% 34.17% 50.00% 12.72% 20.14% -5.87% 40.00% 34.31% -8.69%
15.60 26.60 9.53 3.50 7.59 1.58 1.02 3.01 5.71 -4.87 1.08 1.33 9.02
EPS in Rs 2.04 3.47 1.24 0.46 0.99 0.21 0.13 0.39 0.75 -0.64 0.14 0.17 1.18
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
100 105 124 132 134 125 150 133 163 197 170 174
111 112 129 145 137 137 144 136 165 171 162 170
Operating Profit -10 -7 -4 -13 -3 -12 6 -3 -2 25 8 4
OPM % -10% -7% -3% -10% -2% -9% 4% -2% -1% 13% 5% 2%
16 2 13 95 -2 25 8 24 40 33 12 10
Interest 9 11 10 4 5 3 3 4 3 2 3 4
Depreciation 14 3 5 17 4 2 2 3 2 2 3 4
Profit before tax -16 -20 -6 62 -14 8 8 15 33 54 15 7
Tax % -11% -3% -13% 22% -34% 84% 48% 6% 10% 13% 25% 15%
-18 -20 -7 48 -18 1 4 14 29 47 11 6
EPS in Rs -2.39 -2.64 -0.87 6.28 -2.38 0.17 0.55 1.83 3.83 6.16 1.45 0.74
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 5%
5 Years: 3%
3 Years: 2%
TTM: 2%
Compounded Profit Growth
10 Years: 9%
5 Years: 6%
3 Years: -21%
TTM: -50%
Stock Price CAGR
10 Years: 27%
5 Years: 28%
3 Years: -7%
1 Year: 133%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 15%
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 77 77 77 77 77 77 77 77 77 77 77 77
Reserves -59 -79 -86 -38 -51 -50 -46 -32 -3 43 54 60
39 42 46 47 42 43 40 31 28 27 42 46
110 128 132 94 93 128 144 111 108 84 73 67
Total Liabilities 167 167 169 180 160 197 214 186 210 231 246 250
98 94 91 72 72 59 58 57 57 58 85 88
CWIP 0 0 1 9 3 14 24 0 1 12 4 0
Investments 1 1 1 8 5 5 9 18 27 33 32 30
67 71 76 92 80 119 123 110 125 128 125 133
Total Assets 167 167 169 180 160 197 214 186 210 231 246 250

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-3 11 -8 -75 5 -7 19 -7 -2 11 6 5
-0 -1 10 80 -3 18 -9 17 10 5 -17 -1
3 -8 -1 -3 -6 -2 -6 -14 -6 -19 9 -3
Net Cash Flow -1 2 1 2 -4 8 3 -4 2 -3 -2 1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 101 95 74 83 79 100 84 79 87 52 58 55
Inventory Days 92 95 86 72 66 75 61 76 58 48 62 58
Days Payable 142 178 139 135 138 207 191 184 184 151 131 133
Cash Conversion Cycle 51 12 22 20 6 -32 -46 -29 -39 -50 -11 -19
Working Capital Days -161 -219 -204 -47 -89 -98 -120 -74 -37 18 35 41
ROCE % -14% -16% -19% -44% -1% -5% 16% 25% 18% 34% 11%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
30.76% 30.76% 30.76% 30.76% 30.76% 30.76% 30.77% 30.77% 30.78% 30.78% 30.78% 30.78%
0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
69.24% 69.24% 69.24% 69.24% 69.24% 69.23% 69.23% 69.22% 69.22% 69.23% 69.21% 69.23%
No. of Shareholders 1,90,3541,85,7491,82,9461,81,2131,81,5891,80,1991,79,4041,78,2741,77,7431,75,2221,71,9441,70,079

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents